The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View pso content recommended for you
What is teledermatology and does it have a place in the management of psoriasis?
The Psoriasis and Psoriatic Arthritis Hub was pleased to speak with Peter van de Kerkhof, Radboud University, Nijmegen, NL. We asked, What is teledermatology and does it have a place in the management of psoriasis?
What is teledermatology and does it have a place in the management of psoriasis?
In this interview, van de Kerkhof outlines the drivers for the development of telemedicine during the COVID-19 pandemic and provides context for why this was vital to facilitate treatment when face-to-face consultations were difficult. Van de Kerkhof weighs the benefits and drawbacks of the use of photos and video conferencing, with a focus on privacy, and equipment and internet accessibility as barriers. Van de Kerkhof also looks at where telemedicine can be successfully implemented, noting scenarios where face-to-face consultation is still required to effectively treat a patient. This interview concludes with a look at the future applications of telemedicine, considering its use in conjunction with typical consultations and the patient experience.
